New analyses of two AZD7442 COVID-19 phase-III trials in high-risk populations confirm robust efficacy and long-term prevention Read more
India has robust manufacturing capability with sufficient skilled manpower to foster innovation Read more
Approved antibiotics and those under clinical development are insufficient to arrest AMR: Rex Clements, Centrient Pharmaceuticals Read more
Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from US FDA Read more